China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) — Capital Reinvestment Ratio
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Capital Reinvestment Ratio of 2.38x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥126.71 Million) in capital expenditures (CN¥302.02 Million). See China Resources Sanjiu Medical & Pharmac (000999) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2024)
This chart tracks China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 25 annual periods.
Annual Capital Reinvestment Ratio for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
Year-by-year Capital Reinvestment Ratio for China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2024. For live market cap and broader valuation context, see how much is China Resources Sanjiu Medical & Pharmac worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥4.40 Billion | CN¥790.07 Million | ▼ -11.6% |
| 2023 | 0.20x | CN¥4.22 Billion | CN¥857.21 Million | ▼ -35.8% |
| 2022 | 0.32x | CN¥3.01 Billion | CN¥951.57 Million | ▼ -32.0% |
| 2021 | 0.47x | CN¥1.87 Billion | CN¥870.80 Million | ▲ +66.5% |
| 2020 | 0.28x | CN¥2.22 Billion | CN¥621.82 Million | ▲ +2.9% |
| 2019 | 0.27x | CN¥1.97 Billion | CN¥535.97 Million | ▼ -13.5% |
| 2018 | 0.31x | CN¥1.91 Billion | CN¥600.36 Million | ▲ +30.8% |
| 2017 | 0.24x | CN¥1.56 Billion | CN¥374.74 Million | ▼ -5.6% |
| 2016 | 0.25x | CN¥1.39 Billion | CN¥354.33 Million | ▼ -3.0% |
| 2015 | 0.26x | CN¥1.26 Billion | CN¥330.65 Million | ▼ -8.9% |
| 2014 | 0.29x | CN¥1.18 Billion | CN¥341.22 Million | ▲ +19.1% |
| 2013 | 0.24x | CN¥1.47 Billion | CN¥354.89 Million | ▼ -41.9% |
| 2012 | 0.42x | CN¥1.21 Billion | CN¥504.52 Million | ▼ -3.0% |
| 2011 | 0.43x | CN¥954.90 Million | CN¥409.79 Million | ▲ +34.8% |
| 2010 | 0.32x | CN¥848.28 Million | CN¥270.00 Million | ▲ +41.1% |
| 2009 | 0.23x | CN¥855.05 Million | CN¥192.93 Million | ▼ -79.1% |
| 2008 | 1.08x | CN¥1.12 Billion | CN¥1.20 Billion | ▲ +187.7% |
| 2007 | 0.37x | CN¥605.30 Million | CN¥226.78 Million | ▲ +17.4% |
| 2006 | 0.32x | CN¥425.51 Million | CN¥135.81 Million | ▼ -80.4% |
| 2005 | 1.63x | CN¥22.83 Million | CN¥37.14 Million | ▼ -66.4% |
| 2003 | 4.84x | CN¥28.09 Million | CN¥135.88 Million | ▲ +1289.6% |
| 2002 | 0.35x | CN¥496.12 Million | CN¥172.67 Million | ▼ -55.1% |
| 2001 | 0.77x | CN¥153.44 Million | CN¥118.83 Million | ▲ +21.2% |
| 2000 | 0.64x | CN¥266.86 Million | CN¥170.58 Million | ▲ +5.0% |
| 1999 | 0.61x | CN¥120.63 Million | CN¥73.43 Million | — |